Alan Weintraub
Developmental - Behavioral Pediatrics · Norcross, GANPI 1447295431
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $58,117 of the $65,927 with a category attached, or 88.2%. Ironshore Pharmaceuticals Inc. accounts for 63.3% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2021 at $28,243 and has fallen 87.1% since, to $3,632 in 2022.
Across 161 payments — averaging $409.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ironshore Pharmaceuticals Inc.$42K
- Corium, LLC$13K
- Supernus Pharmaceuticals, Inc.$11K
- Tris Pharma Inc$179
- Neos Therapeutics, LP$88
- Sunovion Pharmaceuticals Inc.$87
- plus $263 from 6 others
What the payments were for
- Consulting fees$3,6005%
- Speaking & faculty fees$58,11788%
- Travel & lodging$1,7963%
- Food & beverage$2,4144%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ironshore Pharmaceuticals Inc. | 91 | $41,749 |
| Corium, LLC | 14 | $12,711 |
| Supernus Pharmaceuticals, Inc. | 29 | $10,850 |
| Tris Pharma Inc | 4 | $179 |
| Neos Therapeutics, LP | 4 | $88 |
| Sunovion Pharmaceuticals Inc. | 5 | $87 |
| Otsuka America Pharmaceutical, Inc. | 4 | $69 |
| Adlon Therapeutics L.p. | 3 | $52 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $45 |
| Shire North American Group Inc | 2 | $36 |
| Lilly USA, LLC | 1 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $30 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Jornay PM 20mg capsules (Bottle of 100)$24,037
- JORNAY PM$16,208
- Azstarys$12,600
- QELBREE$6,250
- Dyanavel XR$122
How this compares
Too few developmental - behavioral pediatrics providers in Georgiato place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lamotrigine | 24 | $93 |
| Fluoxetine Hcl | 12 | $26 |
Paid to pharmacies, not to this prescriber.
Other developmental - behavioral pediatrics in Norcross
- Jack MillerCarrollton$26K
- Doris GreenbergSavannah$2K
- Sonia GeorgeMarietta$932
- Rachel GoodsonMacon$882
- Elizabeth YoungMacon$433
- Nancy CarnevaleDalton$359
- Emily BrandtDalton$206
- Dennis ObanionAtlanta$33
- Margaret EllisSavannah$31
- Jinsook HuhAugusta$20
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.